Clinical, scientific and ethnographic studies of influenza in quarantine

Expert Review of Vaccines

Volumn 11, Issue 8, 2012, Pages 929-937

  Oxford, John S ^a,b   Oxford, Juliette R ^a,b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

antivirals; ethnography; host genes; influenza; quarantine; vaccines

Indexed keywords

INFLUENZA VACCINE; M PROTEIN; OSELTAMIVIR;

CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; ETHNOGRAPHY; HUMAN; INFECTION CONTROL; INFLUENZA; INFLUENZA VIRUS A; MEDICAL LITERATURE; NONHUMAN; NOSE SMEAR; PATIENT SELECTION; PRIORITY JOURNAL; REVIEW; SPANISH INFLUENZA; STRESS; THROAT CULTURE; VIRUS EXCRETION; VIRUS TRANSMISSION; VIRUS VIRULENCE;

ANTHROPOLOGY, CULTURAL; BIOMEDICAL RESEARCH; CD4-POSITIVE T-LYMPHOCYTES; CLINICAL TRIALS AS TOPIC; DISEASE TRANSMISSION, INFECTIOUS; HEMAGGLUTINATION TESTS; HOSPITALS, ISOLATION; HUMANS; INFECTION CONTROL; INFLUENZA A VIRUS; INFLUENZA, HUMAN; QUARANTINE; SIGNAL TRANSDUCTION;

EID: 84866708766     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/erv.12.77     Document Type: Review

References (26)

1. Lau LL, Cowling BJ, Fang VJ et al. Viral shedding and clinical illness in naturally acquired influenza virus infections. J. Infect. Dis. 201(10), 1509-1516 (2010).
2. Reynolds D, Garay J, Deamond S, Moran M, Gold W, Styra R. Understanding, compliance and psychological impact of the SARS quarantine experience. Epidemiol. Infect. 1(36), 997-1007 (2008).
3. Cava MA, Fay KE, Beanlands HJ, McCay EA, Wignall R. The experience of quarantine for individuals affected by SARS in Toronto. Public Health Nurs. 22(5), 398-406 (2005).
4. Beare AS, Read SE. The study of antiviral compounds in volunteers. In: Chemoprophylaxis and Virus Infections of the Respiratory Tract. Oxford JS (Ed.). CRC Press, OH, USA, 27-56 (1977).
5. Hayden FG. Experimental human influenza: observations from studies of influenza antivirals. Antivir. Ther. (Lond.) 17(1 Part B), 133-141 (2012).
6. Carrat F, Vergu E, Ferguson NM et al. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am. J. Epidemiol. 167(7), 775-785 (2008).
7. Wahl HR, White GB, Lyall HW. Some experiments on the transmission of influenza 1918. J. Infect. Dis. 25, 419 (1919).
8. Smith W, Andrewes CH, Laidlaw PP. A virus obtained from influenza patients. Lancet 222(5732), 66-688 (1933).
9. Smorodintsev AA, Tushinsky MD, Drobyshevskaya AJ, Korovin AA, Osetroff AJ. Investigation of volunteers infected with the influenza virus. Am. J. Med. Sci. 194, 159-170 (1937).
10. Henle GHG, Stokes J, Maris EP. Experimental exposure of human subjects to viruses of influenza. J. Immunol. 52, 145-165 (1946).
11. Treanor J. Hayden FG. Volunteer challenge studies p517. In: Textbook of Influenza. Nicholson KG, Webster RG, Hay AJ (Eds). Blackwell Science, Oxford, UK (1998).
12. Clements ML, Snyder MH, Sears SD, Maassab HF, Murphy BR. Evaluation of the infectivity, immunogenicity, and efficacy of live cold-adapted influenza B/Ann Arbor/1/86 reassortant virus vaccine in adult volunteers. J. Infect. Dis. 161(5), 869-877 (1990).
13. Jackson GG, Muldoon RL, Akers LW. Serological evidence for prevention of influenzal infection in volunteers by an anti-influenzal drug adamantanamine hydrochloride. Antimicrob. Agents Chemother. (Bethesda) 161, 703-707 (1963).
14. Smorodintsev AA, Zlydnikov DM, Kiseleva AM, Romanov JA, Kazantsev AP, Rumovsky VI. Evaluation of amantadine in artificially induced A2 and B influenza. JAMA 213(9), 1448-1454 (1970).
15. Oxford JS, Gelder C, Lambkin R. Would you volunteer to be quarantined and infected with influenza virus? Expert Rev. Anti. Infect. Ther. 3(1), 1-2 (2005).
16. Oxford JS, McGeoch DJ, Schild GC, Beare AS. Analysis of virion RNA segments and polypeptides of influenza A virus recombinants of defined virulence. Nature 273(5665), 778-779 (1978).
17. Oxford JS, Schild GC, Corcoran T et al. A host-cell-selected variant of influenza B virus with a single nucleotide substitution in HA affecting a potential glycosylation site was attenuated in virulence for volunteers. Arch. Virol. 110(1-2), 37-46 (1990).
18. Killingley B, Enstone J, Booy R et al.; Influenza Transmission Strategy Development Group. Potential role of human challenge studies for investigation of influenza transmission. Lancet Infect. Dis. 11(11), 879-886 (2011).
19. Huang Y, Zaas AK, Rao A et al. Temporal dynamics of host molecular responses differentiate symptomatic and asymptomatic influenza a infection. PLoS Genet. 7(8), e1002234 (2011).
20. Wilkinson TM, Li CK, Chui CS et al. Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans. Nat. Med. 18(2), 274-280 (2012).
21. Nicholson KG. Human influenza p219. In: Textbook of Influenza. Nicholson KG, Webster RG, Hay AJ (Eds). Blackwell Science, Oxford, UK (1998).
22. Hall WJ, Douglas RG Jr, Hyde RW, Roth FK, Cross AS, Speers DM. Pulmonary mechanics after uncomplicated influenza A infection. Am. Rev. Respir. Dis. 113(2), 141-148 (1976).
23. Chadwick J, Mann W. The Medical Works of Hippocrates. Blackwell, Oxford, UK (1950).
24. Ison MG, Campbell V, Rembold C, Dent J, Hayden FG. Cardiac findings during uncomplicated acute influenza in ambulatory adults. Clin. Infect. Dis. 40(3), 415-422 (2005).
25. Greaves K, Oxford JS, Price CP, Clarke GH, Crake T. The prevalence of myocarditis and skeletal muscle injury during acute viral infection in adults: measurement of cardiac troponins I and T in 152 patients with acute influenza infection. Arch. Intern. Med. 163(2), 165-168 (2003).
26. DeVincenzo JP, Wilkinson T, Vaishnaw A et al. Viral load drives disease in humans experimentally infected with respiratory syncytial virus. Am. J. Respir. Crit. Care Med. 182(10), 1305-1314 (2010).